Edelman Steven
Known title: DirectorCIK: 0001683354
Edelman Steven's purchase track record
Edelman Steven has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/10/2025 | SENS | $66K | +27.0% | -8.8% | +8.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| SENS | ▲ Buy | Grant | 2,402 | $13K | 7/1/2026 | View on chart |
| SENS | ▲ Buy | Grant | 9,852 | $0 | 5/20/2026 | View on chart |
| SENS | ▲ Buy | Grant | 1,936 | $13K | 4/1/2026 | View on chart |
| SENS | ▲ Buy | Grant | 2,185 | $13K | 1/2/2026 | View on chart |
| SENS | ▲ Buy | Open Market | 10,000 | $66K | 11/10/2025 | View on chart |
| SENS | ▲ Buy | Grant | 31,174 | $13K | 10/1/2025 | View on chart |
| SENS | ▲ Buy | Grant | 27,048 | $13K | 7/1/2025 | View on chart |
| SENS | ▲ Buy | Grant | 111,386 | $0 | 5/23/2025 | View on chart |
| SENS | ▲ Buy | Grant | 19,363 | $13K | 4/1/2025 | View on chart |
| SENS | ▲ Buy | Grant | 27,219 | $13K | 1/2/2025 | View on chart |
| SENS | ▲ Buy | Grant | 38,193 | $13K | 10/1/2024 | View on chart |
| SENS | ▲ Buy | Grant | 32,529 | $13K | 7/1/2024 | View on chart |
| SENS | ▲ Buy | Grant | 236,344 | $0 | 5/22/2024 | View on chart |
| SENS | ▲ Buy | Grant | 25,245 | $13K | 4/2/2024 | View on chart |
| SENS | ▲ Buy | Grant | 22,991 | $13K | 1/2/2024 | View on chart |
| SENS | ▲ Buy | Grant | 22,991 | $13K | 10/2/2023 | View on chart |
| SENS | ▲ Buy | Grant | 16,248 | $13K | 7/3/2023 | View on chart |
| SENS | ▲ Buy | Grant | 147,948 | $0 | 5/17/2023 | View on chart |
| SENS | ▲ Buy | Grant | 15,156 | $10K | 4/3/2023 | View on chart |
| SENS | ▲ Buy | Grant | 9,375 | $10K | 1/3/2023 | View on chart |
| SENS | ▲ Buy | Grant | 7,371 | $0 | 10/3/2022 | View on chart |
| SENS | ▲ Buy | Grant | 9,466 | $0 | 7/1/2022 | View on chart |
| SENS | ▲ Buy | Grant | 99,557 | $0 | 5/26/2022 | View on chart |
| SENS | ▲ Buy | Grant | 4,977 | $10K | 4/1/2022 | View on chart |
| SENS | ▲ Buy | Grant | 3,511 | $10K | 1/3/2022 | View on chart |
| SENS | ▲ Buy | Grant | 2,798 | $10K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Beta Bionics and Senseonics announce iLet-Eversense 365 integration
Beta Bionics and Senseonics announced a deal to integrate the iLet automated insulin delivery system with the Eversense 365 continuous glucose monitor. This partnership aims to provide a more seamless solution for patients managing diabetes. The news highlights a strategic move to combine two major technologies in the diabetes care market.
Beta Bionics and Senseonics announce iLet-Eversense 365 integration. Beta Bionics and Senseonics announced a deal to integrate the iLet automated insulin delivery system with the Eversense 365 continuous glucose monitor. This partnership aims to provide a more seamless solution for patients managing diabetes. The news highlights a strategic move to combine two major technologies in the diabetes care market.